About 1 Trademarks found for “AETERNA ZENTARIS”

Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of hematological diseases, pharmaceutical preparations used for the treatment of age-related diseases namely diabetes, cardiovascular diseases, age-related macular degeneration (AMD), dementia, pharmaceutical preparations used for the treatment of ophtalmological disorders, pharmaceutical preparations used for the treatment of reproductive system disorders, pharmaceutical preparations used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparations used for the treatment for benign prostatic hyperplasia (BPH), pharmaceutical preparations used for the treatment of tropical diseases related to parasite or virus caused by Black Fever, Cutaneous and Visceral Leismaniasis and Malaria, pharmaceutical preparations used for the treatment of infectious disease for specific problematic bacteria namely M. tuberculosis, B. anthracis, H. pylori, C. difficile and nosocomial diseases, pharmaceutical preparations used for the treatment of leishmaniasis, pharmaceutical preparations used for the treatment of obesity, pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes, pharmaceutical preparations containing cytotoxic products (conjugated or not) in the form of pills or injectable for use in oncology, pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform, pharmaceutical preparations based on bombesin antagonist platform, pharmaceutical preparations based on inhibitors of the Akt pathway, pharmaceutical preparations based on angiogenesis inhibitors platform, pharmaceutical preparations used to induce apoptosis, pharmaceutical preparations used to stimulate growth hormone secretagogue (GHS).